The successful transplantation of autologous and isologous tissue has been achieved for many years. However, the ability of an adult host animal to reject a homograft from another adult animal of a different strain within the same species has prevented successful homotransplantation in adult animals. 
The successful transplantation of autologous and isologous tissue has been achieved for many years. However, the ability of an adult host animal to reject a homograft from another adult animal of a different strain within the same species has prevented successful homotransplantation in adult animals. As early as 1953 Billingham and Sparrow' demonstrated that living donor epidermal cells treated with immune serum were rendered incapable of growth when grafted back onto the original donor. Shortly thereafter, Voisin accelerated the homograft rejection of guinea pig A transplants to guinea pig B by injecting the recipient with serum from a rabbit actively immunized against the skin of guinea pig A. This passive immunity to guinea pig A skin transplants could also be transferred to guinea pig A and to guinea pig C. Further manifestations of a skin-specific antigen were discovered when the rabbit developed alopecia, epithelium thinning, and necrosis of superficial hair follicles. In 1960, this auto-allergic phenomenon was confirmed by Chytilova et al.' Further indications that the immunological response of the host to a homograft plays an important role in determining the time survival of the homograft were noted when Medawar demonstrated that specific leukocytes could immunize males and females against the graft; when Bollage0 detected antibodies in the recipient's serum to the tissue extracts of the donor; when Hildemann demonstrated that the survival time of a homograft could be decreased by the injection of various numbers of the homologous spleen cells prior to the homotransplantation; when Muller' induced the clouding of transplanted corneas by the intraperitoneal injection of donor skin into the recipient; when Medawar" noted that the length of survival of a homograft varies inversely with its size; when Gorer'1 noted an antibody titer increase following a second incompatible graft; and when Stetsone8 noted that the white graft immunity could be passively acquired by immune serum. In the face of such preponderant evidence that the immunological apparatus of the recipient was largely responsible for the inability of a homograft to take, many attempts were made to completely destroy or avoid the normal immunological apparatus of the host. Sublethal doses of X radiation and antimetabolites were used in various manners with variable results,"''' and thymectomy was found to be of dubious value "' in prolonging the life of homografts. Lapp achieved good success in the homotransplantation of embryonic tissue" and Schubert demonstrated that people with congenital agammaglobulinemia have a tendency to tolerate homografts for prolonged periods of time whereas people with acquired agammaglobulinemia do not."
Perhaps the most common way to prolong homografts has been to inject the recipient in its neonatal period with donor cells,' thereby rendering it unable to form antibodies to this specific donor antigen in its adulthood and unable to reject a graft from the donor. Although this last method has been quite successful, many workers have noted that when newborn mice, rats, or chicks are injected with homologous lymphoid tissue, many develop the "runting syndrome"4'"' which is characterized by a failure to grow at a normal rate, diarrhea,7"' anemia, positive direct Coombs test," splenomegaly"'"9, hepatomegaly,9"'8 and involution of their lymphoid tissue.""4"' This phenomenon would certainly make most workers agree that an application of this process to humans could be potentially dangerous and unwise.
In 1961, Howard' demonstrated that even the immunologic reactivity of adult mice could be depressed by the parental strain spleen cells and in 1962, Binete noted that the graft produces large immunologically competent mononuclear cells. Further evidence of graft versus host reaction was demonstrated by the vascular changes that accompany a homograft rejection. The graft initially receives its blood supply from three sources: 1) a direct connection of the graft's vessels with the host's vessels; 2) the vascularization of the graft's dermal tissue by the host's ingrowing vessels; 3) by the ingrowth of recipient vessels into endothelial vessels of the graft. '7 Within two weeks after the transplantation, rouleaux accumulate in the blood vessels of the graft, thrombi are formed, and the capillaries are ruptured leading to widespread hemorrhage, necrosis, and rejection of the graft." The formation of the rouleaux, the destruction of host blood vessels 32 Volume 38, August, 1965 Skin homograft survival M proliferating into the graft, and the inverse relationship between the graft survival time and its size as noted by Medawar,'3 might very well indicate a graft reaction against the recipient.
The survival time of grafts is even affected by the sex of the donor or recipient as revealed by Eichwald's finding"'u in 1955 and 1961 that intrastrain grafting in A/Jax mice was successful from male to male and from female to female, but that isologous grafts from male to female were generally rejected. In 1957, Peer"' noted that grafts from grandfathers and from fathers were rejected by infants, whereas mothers' grafts to infants were prolonged. In 1958, Voisine noted that female grafts on males had shorter survival times than did male grafts on females.
The graft survival time of mice is also affected by the histocompatible gene difference between the donor and recipient. Autologous and isologous grafts of well-inbred mice are readily accepted as were the grafts from male F1 hybrids of reciprocal parentage in Eichwald's work of 1958.' He noted, however, that a second-set response occurred when an F1 male was grafted from a male of pure strain of one of its parents. This work demonstrates that rejection may be the result of a very slight histocompatible gene difference between the donor and host and reveals the difficulty manifest in attempting to find a donor type completely compatible to the host and vice versa.
If one is to achieve success in transplanting tissue between adult animals, it would seem that one must eliminate or depress both the ability of the host to react against the homograft and the ability of the graft to react against the host. One way to prevent an adult animal from reacting against an antigen is to completely overwhelm the immunological apparatus of that animal with the antigen, producing immunological paralysis in the manner that Felton rendered mice incapable of forming antibodies to the pneumococcal capsular polysaccharide.M As early as 1925 Rhodes prolonged the survival time of homografts by the injections of skin antigen into the host.' In 1952 Allen succeeded in prolonging skin graft survival from 7 to 23 days in rabbits by injecting into the recipient products of donor skin treated by the quick-freeze method.' He and Randall'2 also noted at this time that ACTH did not prolong the survival time of skin homografts nor did Allen find that ACTH potentiated the desensitization process. In 1954 Werder was able to produce prolongation of skin graft survival by applying consecutive homografts to mice, thereby indicating that perhaps the immune response of the host could be diminished or eliminated."' Assuming that the effect was immunological paralysis, Hardin and Werder"" then induced prolongation of skin grafts in CFW mice by subcutaneous injections of skin 33 POMEROY YALE JOURNAL OF BIOLOGY AND MEDICINE extract into the host. Some of the grafts were still viable at the end of six months. In 1956, Billingham et aL prolonged the survival of homografts for several days by injecting strain A or CBA mice with reconstituted suspensions of lyophilized homologous tissues prior to homotransplantation6 and in 1952, Stark prolonged the life of homografts in adult rabbits by at least 100 per cent by the subcutaneous injections of homologous whole blood prior to homotransplantation.'4 By using extracts and red blood cells to produce immunological paralysis, one avoids producing the runting syndrome, which would be one of the major hazards were attempts made to produce tolerance to grafts from a specific donor in newborn children. However, one cannot avoid introducing immunologically competent cells in a homotransplant unless the donor has also been immunologically paralyzed prior to the homotransplantation.
The experiment described in this paper consequently was designed to achieve suppression of both normal grafting responses: that of the host against the graft, and that of the graft against the host. In 1962 Pomeroy and Crelin achieved permanent takes in skin homotransplants from strain A/SG mice onto strain CBA/SG mice after treating strain A/SG mice with CBA/SG mice skin antigens before transplanting and strain CBA/SG mice with strain A/SG skin antigens before and after homotransplantation.'1 In this experiment, both donor and host were treated with homologous antigenic preparation in order to prevent the graft from rejecting the host and the host from rejecting the graft. Young male mice were utilized in order to avoid any rejections because of sex variation and to avoid the possibility that older mice might not be capable of rejecting a homograft as readily as young mice, a phenomenon observed by Medawar and Sparrow, but not by Krohn.' Mice strains A/SG, A/Hej, and CBA/SG were utilized because of Barnes' work' which ruled out the possibility of natural acceptance of homografts between these strains. Pooled homologous antigenic preparation was utilized in order to achieve an antigenic preparation of each strain that would be representative of each mouse in that respective inbred strain. The value of pooled antigenic preparations was evident in the work of Cannon in 1958 when he demonstrated that induced tolerance was "not exclusively individual specific"' and by Lengerova in 1960, who concluded that antigen prepared from at least 40 donors would be necessary in order to produce universal transplantation immunity or tolerance.'
These respective homologous antigenic preparations were stored in 30 ml. Skin hotnograft survival I POMEROY retains its antigenicity. The thawed product was then preserved with a 1/10,000 tincture of merthiolate in order to avoid nonspecific graft survival time which has been shown by Billingham to occur when phenol is used as a preservative.' The present work is an elaboration and extension of this preliminary study.
MATERIALS AND METHODS
A total of 128 young adult male mice of the inbred strains CBA/SG*, A/SG*, and A/HEJ** were used as donors and/or recipients of homologous skin grafts after they had been treated three times a week for variable periods with varying doses of a homologous antigenic preparation (HAP)t as follows:
1. CBA/SG antigen was prepared by homogenizing skin, liver, kidney, and muscle of male mice from an inbred CBA/SG strain on a Virtis 23 Homogenizer fitted with an adapter to utilize Marco Stainless Steel Blades, No. 16-108. The homogenate was diluted to a 50 g/100 ml. suspension with 0.85 g/100 ml. ice cold saline. After centrifugation, the supernatant was frozen in 30 ml. aliquots in No. 2320 vaccine bottles and thawed as needed. The thawed product was preserved by adding tincture of merthiolate to a 1/10,000 concentration. 2 . A/SG antigen was prepared in the same manner as CBA/SG antigenic preparation except that only muscle and skin of male mice of an inbred A/SG strain were used. 3 . A/Hej antigen was prepared exactly in the same manner as No. 2. The mice were grouped as follows (Table 1) :
Group I: Male mice of the strains of CBA/SG, A/SG, and A/Hej received no treatment or homografts. Skin sections were examined after preparation for study by light microscopy.
Group II: Five mice of the CBA/SG strain received ten homografts from five A/SG mice. Mice of this group were used to study the fate of the grafts with no treatment.
Group III: Five mice of the CBA/SG strain received five homografts from five A/SG mice after both donor and recipient had received 13 0.2 ml., 16 0.3 ml., and 6 0.6 ml. intraperitoneal injections of tincture of merthiolate.t Recipients received eight 0.3 ml. injections of 1/10,000 tincture of merthiolate post-operatively. The grafts in mice of this group were examined macroscopically and microscopically. Group VII: Five mice of the CBA/SG strain received five homotransplants from five A/SG strain mice after both donor and recipient had received 13 0.2 ml. and 6 0.3 ml. injections of HAP. Recipients received 11 0.3 ml. injections of HAP postoperatively.
Group VIII: Two CBA/SG strain mice received homografts from two A/SG strain mice after both donor and recipient had been treated with 13 0.2 ml. and 5 0.3 ml. injections of HAP. Recipients received 11 0.3 ml. injections of HAP post-operatively.
Group IX: Thirty CBA/SG mice received 60 homografts from 30 A/SG mice after both donor and recipient had been given 16 0.3 ml. injections of HAP. Recipients were treated with 3 0.6 ml. injections of HAP post-operatively.
Group X: Twenty-eight CBA/SG mice received 56 homografts from 28 A/Hej mice after both donor and recipient had received 16 0.3 ml. injections of HAP. Recipients received post-operatively 3 0.6 ml. injections of HAP.
Group XI: Twenty-six A/SG mice received 52 homografts from 26 CBA/SG mice after both donor and recipient were given 16 0.3 ml. injections of HAP.
Group XII: Twenty-two mice of the A/Hej strain received 44 homografts from 22 CBA/SG strain mice after both donor and recipient had received 16 0.3 ml. injections of HAP.
Group XIII: Six CBA/SG mice received six homografts from six A/SG mice after both donor and recipient had been given 13 0.2 ml., 6 0.3 ml., and 6 0.6 ml. injections of HAP.
Skin homotransplantation was performed on donor and recipient mice under sodium amytal-ether anesthesia in a manner similar to that developed by Gross and Gottfried.2' Anesthetized mice were placed on an operating board so that all extremities were held down by elastic bands. All hair was then shaved off the dorsum of each animal with a Progienic Electric Clipper, Model No. 11, utilizing a No. 50 Unitary Cutting Assembly. The skin was then washed with 100 per cent alcohol and a 3-inch strip of Surgical Tape, No. 1530, produced by the Minnesota Mining and Manufacturing Company, was applied firmly to the backs of the two animals. The tape, still applied to the skin, was pinched in the midline and two full-thickness grafts were then produced with a Weck Stainless Steel Skin Graft Punch (Fig. 1) . The two skin grafts of each animal were then immediately transferred to the graft bed produced in the reciprocal animal after penicillin powder and a drop of streptomycin (.0011 gm/ml.) had been instilled into the bed (Figs. 2 and 3) . Each animal was both a donor and a recipient of two skin transplants. This enabled a determination of whether a rejection was due to an infected graft or to inadequate treatment. A four-inch strip of Surgical Tape, No. 1530, was then spread over the tape already existing on the dorsum of the animal, covering and adhering to the tape affixed to each graft, thereby holding each graft in place. The tape was then drawn tightly together girding the animal just proximal to the lower extremities (Fig. 4) . Gauze was placed over the graft areas and then adhesive tape was placed over the gauze and the surgical tape to protect the graft. The animals were housed in groups of 2 or 3 throughout the rest of the project.
In some groups, (see Table 2 ) each animal received two homologous skin transplants, whereas in other groups, the animals received two isologous skin grafts or one Skin homograft survival I POMEROY homologous skin graft and one autologous skin graft in order to determine the degree to which each strain was inbred and whether the grafting procedure was effective.
RESULTS
After transplantation, the bandages were removed at varying lengths of time from representative animals in some groups to note the changes in the grafts. The animals were then sacrificed or the bandages were replaced until the grafts were sufficiently accepted macroscopically and at that time, the bandages were removed from all mice within the respective group.
Viability of the homografts was judged in accordance with the macroscopic characteristics of the isologous grafts in Group VI which were all accepted, and necrosis of the homografts was judged in accordance with the characteristics of Group II in which neither the donor nor the recipient was treated with HAP (homologous antigenic preparation) or tincture of merthiolate. By this method, grafts which appeared soft, light pink, and somewhat waxy after the removal of the epidermal cap, along with the removal of the protective tapes, were judged to be viable. Those grafts that were hard, edematous, grossly infected, of cheesy appearance, or dark pink were judged to be necrotic.
Both homologous and isologous grafts from the agouti CBA/SG strain maice were devoid of pigment when the protective tapes were removed. The areas surrounding the grafts were pigmented and, in rare instances some pigment extended into a graft. Lack of pigmentation persisted in these grafts until the recipients were sacrificed. No hair grew in any of the homografts in Groups II-V and IX-XII. When a homograft was rejected belatedly by a recipient that had been treated with HAP, a shallow punched-out ulcer was produced in the graft bed which quickly healed by secondary closure. Within several months after this delayed rejection, the scar had contracted to such an extent that it was almost as difficult to detect as that produced in the initial rejection of a homograft by an untreated mouse.
No infected grafts were included in the results nor were grafts on animals that removed tapes and grafts before the time determined for the tape removal. After different intervals, representative grafts were photographed and fixed in modified Bouin's solution, embedded in paraffin, sectioned serially at 7, and stained with hematoxylin and eosin.
Group I: The microscopic appearance of the normal skin from the strains of mice used in the experiment are shown in Figures 9-12. 3, Group II: When the protective tapes were removed 11 days after homotransplantation, edematous host tissue surrounded the soft, friable, grossly necrotic homografts of all the mice. The grafts were completely rejected by 13 days. Within two months, the scar tissue had constricted so that the locus of the original graft site was barely discernible.
Group III: When the protective tapes were removed 38 days after homotransplantation, all graft beds were lined with fibrous tissue and no grafts were found.
Group IV: When the protective tapes were removed 46 days postoperatively, seven of the homografts were pink, soft and viable. These grafts persisted through 80 days. At 90 days, four animals still had viable grafts and by 120 days only two of the three remaining mice had viable grafts, two mice having been sacrificed at 89 days post-operatively. These two grafts persisted through 150 days, but were replaced by a shallow punched-out ulcer at 173 days.
Histological sections revealed the homografts to be largely composed of a collagen tissue with no viable glands or hairs.
Group V: When the protective tapes were removed 46 days postoperatively, the grafts were extremely friable and surrounded by edematous host tissue. By 55 days, all grafts had been rejected, leaving a bed of fibrous tissue.
Group VI: When the protective tapes were removed seven days postoperatively, all isologous grafts were viable and remained intact until all the recipients were sacrificed at 175 days post-operatively. The grafts were initially soft and pink. Within two weeks, white hair grew from all grafts, irrespective of the original color of the donor or recipient (Fig. 5) .
CBA/SG mice are agouti and A/SG mice are white.
Histological sections revealed a complete absence of pigment in the hair (Figs. 13 and 14) and skin of all isologous skin transplants, except for a few rare occasions when pigment deposits were detected in the isologous CBA-SG full-thickness skin transplants. Group VII: When the protective tapes were removed at 20 days, two of the grafts were soft, pink, and viable. Hair growth became grossly evident within two months. These grafts persisted for 126 days at which time the recipients were sacrificed (Fig. 7) .
Histological sections revealed numerous viable hair follicles, without pigment, and viable sebaceous glands within the full-thickness skin homografts. 40 Volume 38, August, 1965 Skin homograft survival POMEROY Group VIII: When protective tapes were removed at 20 days, both grafts were soft, pink, and viable. At 32 days post-operatively, white hair grew from the homografts. Recipients were sacrificed at this time.
Histological sections revealed numerous viable hair follicles, lacking pigment, and viable sebaceous glands within the full-thickness skin homografts (Figs. 15 and 16 Group XII: When the protective tapes were removed 45 days postoperatively, 36 soft, pink, viable homografts were intact on 22 of 22 recipients; 9 homografts were absent; and 5 homografts were infected. At 90 41 days, 31 homografts were intact on 21 of 22 mice and when all the mice were sacrificed at 175 days, 16 homografts were intact on 13 of the remaining mice (Fig. 8) .
Microscopic Histological sections revealed numerous viable hair follicles, lacking pigment, and viable sebaceous glands within the full-thickness skin homografts. In one homograft, the white hairs persisted despite the necrosis of the rest of the skin homograft.
DISCUSSION
All homografts to untreated animals were completely rejected within 13 days. The survival time of the homografts in which only the donor had received HAP (homologous antigenic preparation) prior to homotransplantation, persisted to 173 days. However, these homografts were largely composed of collagenous tissue with no viable glands or hairs. This was in contrast to the growth of hair and sebaceous glands in the homografts in which both donor and recipient had been treated with HAP for extended periods of time before and after homotransplantation. Thus, treatment of both the donor and the recipient with HAP before and after homotransplantation might be more than additive since the results exceed those anticipated from treating just the donor or recipient.
Hair growth was noted only in those groups in which both donor and recipient were initially treated with very small amounts of HAP in addition to the large doses of HAP prior to the homotransplantation, and in which the recipient was treated with large doses of HAP postoperatively. This may indicate that an extensive period of sensitization is necessary before one can induce complete immunological tolerance or paralysis in an animal. It may also indicate that tolerance is not as readily induced for the skin appendages as it is for the rest of the full-thickness skin grafts.
The observations by Conway' that autologous skin grafts tend to lose their pigmentation also holds true for isologous and homologous grafts which, in the present work, were devoid of pigment in the skin and its 42 Volume 38, August, 1965 Skin-homograft survival I POMEROY appendages. This loss of pigment in a graft may indicate that the melanocytes do not survive the initial deprivation of blood supply or that they migrate from the graft.
The presence of hair in one homograft in which the hair follicles and sebaceous glands were either necrotic or absent indicates that the presence of hair is not necessarily a sign that the homograft is viable. Conversely, the survival of sebaceous glands and hair follicles within many of the homografts which lack hair in the present experiment also confirms that the presence of hair is not a criterion for survival of a homograft, as observed by Billingham.' Conway's study' indicates that autologous graft hair growth is grossly visible at three weeks. The results of the present study indicate that isologous graft hair growth was grossly visible at approximately two weeks and the homologous hair growth was grossly visible at 32 days.
SUMMARY
Reciprocal immunological tolerance or paralysis was induced by treating both donor and recipient mice for varying periods of time with injections of homologous antigenic preparation (HAP). An antigenic preparation of each inbred strain was produced by homogenizing tissues of many mice of each respective strain after the purity of each respective strain of mice had been confirmed by the complete success of isologous grafting.
One hundred and twenty-eight young adult male mice of the inbred strains A/SG, CBA/SG, and A/Hej were used as donors and/or recipients of homografts after they had been treated with HAP (homologous antigenic preparation) for varying lengths of time. The recipients in some groups were treated with HAP after homotransplantation. Another 21 mice were used as controls.
In this study, the following results were observed: (1) Isologous and homologous CBA skin grafts are devoid of pigment. (CBA/SG strain mice are agouti.) (2) Hair first appeared in isologous grafts at approximately two weeks, whereas it first appeared in homologous grafts at approximately four and one half weeks. 
